General Information of Drug (ID: DMWUZP1)

Drug Name
PMID24157366C35 Drug Info
Synonyms GTPL8554; BDBM50443348; US8669252, 12
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
54670056
TTD Drug ID
DMWUZP1

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cyclopentane carboxamide derivative 2 DMYP5FK N. A. N. A. Patented [2]
Piperidinyl pyrazole derivative 4 DMS8NFJ N. A. N. A. Patented [2]
Pyrrolidine carboxamide derivative 2 DMKDX6W N. A. N. A. Patented [2]
Piperidinyl pyrazole derivative 1 DMWAYXP N. A. N. A. Patented [2]
Benzodihydroisofuran derivative 1 DM249KU N. A. N. A. Patented [2]
Cyclohexane carboxamide derivative 2 DM1A0WU N. A. N. A. Patented [2]
Benzodihydroisofuran derivative 3 DMF6B1I N. A. N. A. Patented [2]
Benzodihydroisofuran derivative 4 DM5IH2O N. A. N. A. Patented [2]
Piperidinyl triazole derivative 4 DMOQJMU N. A. N. A. Patented [2]
Piperidinyl triazole derivative 5 DM4QVD0 N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Prolylcarboxypeptidase (PRCP) TTTJZ4M PCP_HUMAN Inhibitor [1]

References

1 Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors. Bioorg Med Chem Lett. 2013 Dec 1;23(23):6228-33.
2 Prolylcarboxypeptidase (PrCP) inhibitors and the therapeutic uses thereof: a patent review.Expert Opin Ther Pat. 2017 Oct;27(10):1077-1088.